Pyrrolo (2.1-a) dihydroisoquinolines and their use as phosphodiesterase 10a inhibitors

The present invention relates to pyrrolo[2.1-a]dihydroisoquinolines which are inhibitors of phosphodiesterase 10a and can be used for combating cancer.

Saved in:
Bibliographic Details
Main Authors ANDREA SEWING, MICHAEL SCHAUER, OLAF WEBER, STEPHEN J. BOYER, PAUL NAAB, DIETMAR FLUBACHER, NILS BURKHARDT, KARL-HEINZ SCHLEMMER, MARCUS BAUSER, ULRICH NIEWOHNER, THORSTEN-OLIVER REPP, JURGEN STOLTEFUSS, JENS-KERIM ERGUDEN, MARK MIGLARESE
Format Patent
LanguageEnglish
Published 24.06.2002
Edition7
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to pyrrolo[2.1-a]dihydroisoquinolines which are inhibitors of phosphodiesterase 10a and can be used for combating cancer.
Bibliography:Application Number: AU2798502